Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
CEO: Yong Qi Quek. Company website
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) trades at $1.60, down 45.39% on the day, as of Sep 20, 2026 14:58 UTC.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares has a market capitalisation of $34.24M, calculated from the live CUPR share price and shares outstanding.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares generated revenue of $0.00 over the trailing twelve months.
CUPR has traded between $0.28 and $14.80 over the past 52 weeks, and the last price is 89.2% below that high.
No. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is loss-making, with a net margin of -3,229.52% over the trailing twelve months.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in SG .
Yong Qi Quek is the chief executive of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares, which employs 15 people.
QFI Terminal shows CUPR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CUPR in Terminal See plans